127 related articles for article (PubMed ID: 32574310)
1. Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals.
Yang C; Ke C; Yue D; Li W; Hu Z; Liu W; Hu S; Wang S; Liu J
Front Public Health; 2020; 8():249. PubMed ID: 32574310
[No Abstract] [Full Text] [Related]
2. Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.
He XL; Zhou YY; Fu W; Xue YE; Liang MY; Yang BH; Ma WL; Zhou Q; Chen L; Zhang JC; Wang XR
Curr Med Sci; 2021 Dec; 41(6):1096-1104. PubMed ID: 34515914
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of Arbidol in the management of COVID-19 infection.
Jie X; Hongmei Y; Ping F; Kuikui Z; Bohan Y; Rui M
Aging (Albany NY); 2021 Apr; 13(7):9253-9264. PubMed ID: 33811756
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID-19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case series.
Gao W; Chen S; Wang K; Chen R; Guo Q; Lu J; Wu X; He Y; Yan Q; Wang S; Wang F; Jin L; Hua J; Li Q
Virol J; 2020 Oct; 17(1):162. PubMed ID: 33097047
[TBL] [Abstract][Full Text] [Related]
5. How do arbidol and its analogs inhibit the SARS-CoV-2?
Aktas A; Tuzun B; Taskin AH; Sayin K; Ataseven H
Bratisl Lek Listy; 2020; 121(10):705-711. PubMed ID: 32955901
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antiviral effect of Arbidol and Chloroquine in treating COVID-19.
Li M; Yu T; Zhu J; Wang Y; Yang Y; Zhao K; Yi Y; He J; Li C; He J
Ann Palliat Med; 2021 Mar; 10(3):3307-3312. PubMed ID: 33849115
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of arbidol in COVID-19 patients: A retrospective study.
Wei S; Xu S; Pan YH
World J Clin Cases; 2021 Sep; 9(25):7350-7357. PubMed ID: 34616801
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of 54 medical staff with COVID-19: A retrospective study in a single center in Wuhan, China.
Chu J; Yang N; Wei Y; Yue H; Zhang F; Zhao J; He L; Sheng G; Chen P; Li G; Wu S; Zhang B; Zhang S; Wang C; Miao X; Li J; Liu W; Zhang H
J Med Virol; 2020 Jul; 92(7):807-813. PubMed ID: 32222986
[TBL] [Abstract][Full Text] [Related]
9. Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study.
Liu M; Cheng SZ; Xu KW; Yang Y; Zhu QT; Zhang H; Yang DY; Cheng SY; Xiao H; Wang JW; Yao HR; Cong YT; Zhou YQ; Peng S; Kuang M; Hou FF; Cheng KK; Xiao HP
BMJ; 2020 Jun; 369():m2195. PubMed ID: 32522737
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China.
Wang Z; Yang B; Li Q; Wen L; Zhang R
Clin Infect Dis; 2020 Jul; 71(15):769-777. PubMed ID: 32176772
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China.
Lai X; Wang M; Qin C; Tan L; Ran L; Chen D; Zhang H; Shang K; Xia C; Wang S; Xu S; Wang W
JAMA Netw Open; 2020 May; 3(5):e209666. PubMed ID: 32437575
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of arbidol in treatment of naturally acquired influenza].
Wang MZ; Cai BQ; Li LY; Lin JT; Su N; Yu HX; Gao H; Zhao JZ; Liu L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):289-93. PubMed ID: 15266832
[TBL] [Abstract][Full Text] [Related]
13. Efficacy analysis of Arbidol treatment in patients with 2019 novel coronavirus pneumonia: a retrospective cohort study.
Chen N; Wang X; Zhang S; Lin R; Jiang Y
Ann Palliat Med; 2021 Oct; 10(10):10626-10632. PubMed ID: 34763510
[TBL] [Abstract][Full Text] [Related]
14. Interferon-α2b Treatment for COVID-19.
Zhou Q; Chen V; Shannon CP; Wei XS; Xiang X; Wang X; Wang ZH; Tebbutt SJ; Kollmann TR; Fish EN
Front Immunol; 2020; 11():1061. PubMed ID: 32574262
[TBL] [Abstract][Full Text] [Related]
15. Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19.
Liu L; Shi F; Tu P; Chen C; Zhang M; Li X; Li C
Medicine (Baltimore); 2021 Jan; 100(4):e24475. PubMed ID: 33530261
[TBL] [Abstract][Full Text] [Related]
16. A trial of arbidol hydrochloride in adults with COVID-19.
Zhao J; Zhang J; Jin Y; Tang Z; Hu K; Sun H; Shi M; Yang Q; Gu P; Guo H; Li Q; Zhang H; Li C; Yang M; Xiong N; Dong X; Xu J; Lin F; Wang T; Yang C; Huang B; Zhang J; Chen S; He Q; Zhou M; Qu J
Chin Med J (Engl); 2022 Jul; 135(13):1531-8. PubMed ID: 35830201
[TBL] [Abstract][Full Text] [Related]
17. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019.
Lai J; Ma S; Wang Y; Cai Z; Hu J; Wei N; Wu J; Du H; Chen T; Li R; Tan H; Kang L; Yao L; Huang M; Wang H; Wang G; Liu Z; Hu S
JAMA Netw Open; 2020 Mar; 3(3):e203976. PubMed ID: 32202646
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study.
Chen J; Lin S; Niu C; Xiao Q
Expert Rev Respir Med; 2021 Feb; 15(2):257-265. PubMed ID: 32941741
[TBL] [Abstract][Full Text] [Related]
20. Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study.
Yin P; Meng J; Chen J; Gao J; Wang D; Liu S; Guo Q; Zhu M; Zhang G; Liu Y; Li Y; Zhang G
Virol J; 2021 Jul; 18(1):142. PubMed ID: 34238341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
